Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations

Dow Jones

Jan 13, 2025

By Owen Tucker-Smith

Tempus AI shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations.

Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November.

In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million.

Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%.

Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test.

Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com

(END) Dow Jones Newswires

January 13, 2025 10:17 ET (15:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503867575"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503867575\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2503867575?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 23:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503867575","market":"sh","top_or_hot":-1,"title":"Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Owen Tucker-Smith \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations. \n</p>\n<p>\n  Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November. \n</p>\n<p>\n  In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million. \n</p>\n<p>\n  Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%. \n</p>\n<p>\n  Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test. \n</p>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2025 10:17 ET (15:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-13 23:17</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Owen Tucker-Smith \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations. \n</p>\n<p>\n  Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November. \n</p>\n<p>\n  In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million. \n</p>\n<p>\n  Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%. \n</p>\n<p>\n  Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test. \n</p>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2025 10:17 ET (15:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2503867575","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503867575","pubTimestamp":1736781420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Tempus AI shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations.Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November.In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million.Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%.Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"第四季度营收预测低于预期后，Tempus AI股价下跌11.7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"By Owen Tucker-Smith \n\n\nTempus AI shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations. \n\n\n  Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November. \n\n\n  In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million. \n\n\n  Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%. \n\n\n  Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test. \n\n\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2025 10:17 ET (15:17 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}